drugset / Trial / NCT01900795
An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model
Timeline
- Start
- 2013-07
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ibuprofen | Small molecule | 400 mg | Oral |
| Subject | Sunobinop | Small molecule | 4.5 mg | Oral |
Indications
No indication recorded.